Inflation is high. The GDP has shrunk. But the job market has never been better. The Washington Post's Damian Paletta helps make sense of the U.S. economy today.
The last several weeks have seen several dramatic mergers of drug companies. Two experts talk about what these changes will mean for the industry, for stockholders, for drug research, and for consumers.
- Dr. Sidney Wolfe Director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Wayne Pines Consultant to the pharmaceutical industry
Most Recent Shows
From high mortgage rates to shortages that have spread coast to coast, New York Times reporter Emily Badger explains the roots -- and consequences of our country's broken housing system.
Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.
Pills, the right to travel and fetal personhood laws -- Diane talks to Temple University Law School's Rachel Rebouché about what's next in the fight over abortion in the U.S.